News

New research in Headache evaluates the safety of combining atogepant and ubrogepant for episodic migraine. The TANDEM study offers important insights into dual-therapy tolerability — essential reading for clinicians optimizing treatment strategies.

AHS has announced the 2024 research grant recipients, awarding $1.23M to projects advancing headache care. From AI tools to youth-focused interventions, these initiatives will be presented at future AHS meetings and in peer-reviewed journals.

IHA 2025 brought 51 early-career neurologists and researchers together for expert-led sessions, hands-on learning, and mentorship. With a focus on research, clinical practice, and career development, the program continues to shape the future of headache medicine. Applications for IHA 2026 open this summer.

Are you a neurology resident, pediatric neurology resident, or a headache medicine fellow with a passion for headache research, medical education, and writing? Headache: The Journal of Head and Face Pain is looking for dedicated trainees to join its Editorial Board as part of the Resident & Fellows Assistant Editor Team!

The American Headache Society is excited to announce scholarship opportunities now available to attend the 67th Annual Scientific Meeting, the premiere venue for cutting-edge advances in Headache Medicine, taking place June 19-22, 2025 at the Minneapolis Convention Center in Minneapolis, MN.

On behalf of the Scientific Program Committee, AHS is excited to announce we are now accepting the submission of abstracts of original contributions on any topic related to headache for presentation at the 67th Annual Scientific Meeting, being held June 19-22, 2025 at the Minneapolis Convention Center in Minneapolis, MN.

AHS recognizes that to fulfill its core goal of improving the lives of people impacted by migraine and other headache disorders, healthcare advocacy is essential.

Adult neurology residents, pediatric neurology residents, postdoctoral researchers, and headache medicine fellows are eligible to apply for a 2-year term, beginning July 1, 2024 and ending June 30, 2026.

This fall, the American Headache Society is proud to offer two programs dedicated to developing leaders within the Society and field of Headache Medicine. These professional development programs were designed to support AHS members at different stages in their careers.

The American Headache Society (AHS) and National Institute of Neurological Disorders and Stroke (NINDS) request your input during the Headache Research Priorities Public Comment Period.

As an American citizen growing up outside of the United States (mainland), I do not recall celebrating Hispanic Heritage month with particular fervor.

Amaal Starling, MD, FAHS, discusses how doctors also function as migraine warriors 

Home-use oxygen for the treatment of cluster headache has not been a coverable benefit for Medicare and Medicaid beneficiaries. This is despite the therapy being a proven safe and effective way to abort a cluster headache attack.

American Headache Society (AHS) joined with 85 other medical associations and specialty societies in praise of a renewed Congressional pledge to support physician training.